CONTINUUS Pharmaceuticals

About:

Continuus Pharmaceuticals designs, builds, and runs manufacturing processes for pharmaceutical and generic clients.

Website: http://continuuspharma.com

Twitter/X: ContinuusP

Top Investors: National Science Foundation, MassChallenge, IMA Group, Mark Bamforth

Description:

CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. CONTINUUS Pharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.